Digest Network Come funziona
Network
/
Società
Ou
Non verificato

Outlook Therapeutics, Inc.

Di cosa scriviamo

Annunci EconomiciBiotecnologiaMedicina Salute Benessere

3 comunicati stampa

Guarda tutti i comunicati
10/06/2025
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Fonte
Outlook Therapeutics, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
02/06/2025
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
Fonte
Outlook Therapeutics, Inc.
Emittente
GLOBENEWSWIRE
1.00
0
04/12/2024
Biotecnologia
Medicina Salute Benessere
Annunci Economici
Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
Fonte
Outlook Therapeutics, Inc.
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0